These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25174632)

  • 1. The promise and limitations of cash transfer programs for HIV prevention.
    Fieno J; Leclerc-Madlala S
    Afr J AIDS Res; 2014; 13(2):153-60. PubMed ID: 25174632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cash transfers for HIV prevention: A systematic review.
    Stoner MCD; Kilburn K; Godfrey-Faussett P; Ghys P; Pettifor AE
    PLoS Med; 2021 Nov; 18(11):e1003866. PubMed ID: 34843468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case-control study.
    Cluver L; Boyes M; Orkin M; Pantelic M; Molwena T; Sherr L
    Lancet Glob Health; 2013 Dec; 1(6):e362-70. PubMed ID: 25104601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of cash transfers for HIV prevention--are we there yet?
    Taaffe J; Cheikh N; Wilson D
    Afr J AIDS Res; 2016; 15(1):17-25. PubMed ID: 27002355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential of a conditional cash transfer intervention to reduce HIV risk among young women in Iringa, Tanzania.
    Kennedy CE; Brahmbhatt H; Likindikoki S; Beckham SW; Mbwambo JK; Kerrigan D
    AIDS Care; 2014; 26(3):275-81. PubMed ID: 23926908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cash plus care: social protection cumulatively mitigates HIV-risk behaviour among adolescents in South Africa.
    Cluver LD; Orkin FM; Boyes ME; Sherr L
    AIDS; 2014 Jul; 28 Suppl 3():S389-97. PubMed ID: 24991912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cash transfers for HIV prevention: considering their potential.
    Heise L; Lutz B; Ranganathan M; Watts C
    J Int AIDS Soc; 2013 Aug; 16(1):18615. PubMed ID: 23972159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can money prevent the spread of HIV? A review of cash payments for HIV prevention.
    Pettifor A; MacPhail C; Nguyen N; Rosenberg M
    AIDS Behav; 2012 Oct; 16(7):1729-38. PubMed ID: 22760738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability and feasibility of cash transfers for HIV prevention among adolescent South African women.
    MacPhail C; Adato M; Kahn K; Selin A; Twine R; Khoza S; Rosenberg M; Nguyen N; Becker E; Pettifor A
    AIDS Behav; 2013 Sep; 17(7):2301-12. PubMed ID: 23435698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results.
    Pettifor A; MacPhail C; Selin A; Gómez-Olivé FX; Rosenberg M; Wagner RG; Mabuza W; Hughes JP; Suchindran C; Piwowar-Manning E; Wang J; Twine R; Daniel T; Andrew P; Laeyendecker O; Agyei Y; Tollman S; Kahn K;
    AIDS Behav; 2016 Sep; 20(9):1863-82. PubMed ID: 26891839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cash transfers for HIV prevention: what do young women spend it on? Mixed methods findings from HPTN 068.
    MacPhail C; Khoza N; Selin A; Julien A; Twine R; Wagner RG; Goméz-Olivé X; Kahn K; Wang J; Pettifor A
    BMC Public Health; 2017 Jul; 18(1):10. PubMed ID: 28697762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic costs of HIV/AIDS prevention activities in sub-Saharan Africa.
    Kumaranayake L; Watts C
    AIDS; 2000; 14 Suppl 3():S239-52. PubMed ID: 11086868
    [No Abstract]   [Full Text] [Related]  

  • 18. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
    Dowdy DW; Sweat MD; Holtgrave DR
    AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV in adolescents in sub-Saharan Africa.
    Cowan F; Pettifor A
    Curr Opin HIV AIDS; 2009 Jul; 4(4):288-93. PubMed ID: 19532066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV prevention cost-effectiveness: a systematic review.
    Galárraga O; Colchero MA; Wamai RG; Bertozzi SM
    BMC Public Health; 2009 Nov; 9 Suppl 1(Suppl 1):S5. PubMed ID: 19922689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.